Patients receiving chemotherapy for lung cancer usually modify their lung function during treatment with increases in forced expiratory volume in 1 second (FEV(1)) and forced vital capacity (FVC) and decreases in lung diffusion for carbon monoxide (DLCO). This prospective study was designed to evaluate functional changes in forced expiratory volume in 1 second, forced vital capacity, and DLCO after three courses of induction chemotherapy with cisplatinum and gemcitabine in stage IIIa lung cancer patients and to assess their impact on respiratory complications after lung resection
Respiratory function changes after chemotherapy : an additional risk for postoperative respiratory complications? / F. Leo, P. Solli, L. Spaggiari, G. Veronesi, F. de Braud, M.E. Leon, U. Pastorino. - In: ANNALS OF THORACIC SURGERY. - ISSN 0003-4975. - 77:1(2004 Jan), pp. 260-265. [10.1016/S0003-4975(03)01487-5]
Respiratory function changes after chemotherapy : an additional risk for postoperative respiratory complications?
L. Spaggiari;F. de Braud;
2004
Abstract
Patients receiving chemotherapy for lung cancer usually modify their lung function during treatment with increases in forced expiratory volume in 1 second (FEV(1)) and forced vital capacity (FVC) and decreases in lung diffusion for carbon monoxide (DLCO). This prospective study was designed to evaluate functional changes in forced expiratory volume in 1 second, forced vital capacity, and DLCO after three courses of induction chemotherapy with cisplatinum and gemcitabine in stage IIIa lung cancer patients and to assess their impact on respiratory complications after lung resection
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
